Search for stocks /

Zydus Wellness buys UK’s Comfort Click for ₹2,300+ cr: Vitamins, gummies & pet health go global

Opening Hook

While Dalal Street was still digesting Reliance’s green energy musings, Zydus Wellness quietly pulled off a ₹2,300+ crore overseas binge. On 29th August 2025, its UK arm Alidac acquired Comfort Click Limited (CCL), a digital-first vitamins, minerals & supplements (VMS) player with turnover of GBP 134 million (~₹1,430 cr). Why now? Because the global wellness market isn’t waiting—Europe’s VMS industry alone is ~GBP 11 bn, and CCL has clocked a 57% CAGR in five years. India’s sugar-free maker is now selling collagen gummies to kids in London and multivitamins to dogs in Berlin. And yes, this is Zydus’ first-ever foreign buyout—worth chewing over.

At a Glance

  • Deal size GBP 239 mn – That’s ~₹2,300 cr, not pocket change for stevia sachets.
  • Comfort Click turnover GBP 134 mn – Grew from GBP 52 mn in FY23; FT called it top-1000 fastest growing.
  • EBITDA GBP 21 mn – Yes, even gummies sweat margins.
  • Three brands – WeightWorld (adults), maxmedix (kids), Animigo (pets).
  • Channel mix – 80%+ via e-commerce/D2C, no kirana store headaches.
  • Strategic logic – Expands Zydus from Glucon-D to global gummies.

Management’s Key Commentary

Sharvil Patel, Chairman:
“The global acquisition marks a step in empowering consumers and shaping future wellness.”
→ Translation: From sugar-free pills to TikTok gummies, we want it all.

Tarun Arora, CEO:
“Aligns with our strategic vision of expanding Zydus’ international footprint.”
→ Translation: Finally, something more exotic than launching Complan Nutrigro.

On nuclear growth (oops wrong call, here supplements):
“CCL is digital-first, consumer-centric and innovation-driven.”
→ Translation: We just bought the Nykaa of vitamins.

On synergies:
“Acquisition expected to be EPS accretive.”
→ Translation: Relax, analysts—your Excel models won’t faint.

On portfolio:
“Adult, paediatric, and pet nutrition categories drive diversification.”
→ Translation: If kids don’t eat gummies, the family dog surely will.

On vision:
“We’re exploring scalable, sustainable models in personalised wellness.”
→ Translation: Fancy way of saying: more SKUs, more clicks.

Numbers Decoded

MetricFY23FY24FY25 (unaudited)Analysis
Revenue – The HeroGBP 52 mnGBP 85 mnGBP 134 mnA CAGR of 57%—Zydus bought a running treadmill.
EBITDA – The SidekickGBP 21 mnMargins lean but improving—protein bars > Glucon-D sachets.
Turnover CAGR – The Drama Queen5 years: 57%Even crypto bros would envy this chart.

Analyst Questions

  • Why pay GBP 239 mn? Because VMS is GBP 11 bn in Europe.
    → Translation: Growth story > sticker shock.
  • Working capital strain? Comfort Click runs D2C, cash cycles cleaner.
    → Translation: No kirana wallahs chasing 90-day credit.
  • Synergy with Zydus
error: Content is protected !!